Navigation Links
Amgen’s First Quarter 2011 Revenue Increased 3 Percent to $3.7 Billion
Date:4/20/2011

U.S.

42-Total product sales

$ 3,618$ 3,528U.S.$ 2,778$ 2,677International

840851Total product sales

$ 3,618$ 3,528Amgen Inc.Condensed Consolidated Balance Sheets - GAAP(In millions)(Unaudited)March 31, December 31,20112010AssetsCurrent assets:Cash, cash equivalents and marketable securities

$
5,358$
7,422Trade receivables, net

2,5172,335Inventories

2,0982,022Other current assets

1,7161,350Total current assets

21,68923,129Property, plant and equipment, net

5,4555,522Intangible assets, net

2,8082,230Goodwill

11,50411,334Other assets

1,2581,271Total assets

$
42,714$
43,486Liabilities and Stockholders' EquityCurrent liabilities:Accounts payable and accrued liabilities

$
4,166$
4,082Current portion of convertible notes

832,488Total current liabilities

4,2496,570Convertible notes

2,2462,296Other long-term debt

8,5788,578Other non-current liabilities

2,6572,098Stockholders' equity

24,98423,944Total liabilities and stockholders' equity

$
42,714$
43,486Shares outstanding

933932Amgen Inc.Reconciliation of GAAP Debt Outstanding to "Adjusted" Debt Outstanding(In millions)(Unaudited)March 31, 2011GAAPAdjustments for

accounting

standard"Adjusted"Total debt outstanding

$ 10,907$
254

(a) $  11,161(a)To exclude the impact of adopting an accounting standard on January 1, 2009 that changed the method of accounting for our convertible notes.Amgen Inc.Reconciliation of GAAP EPS Guidance to "Adjusted"EPS Guidance for the Year Ending December 31, 2011(Unaudited)On April 20, 2011, the Company reaffirmed its “Adjusted” EPS guidance to be in the range of $5.00 to $5.20.The following table shows a reconciliation of GAAP EPS (diluted) guidance to “Adjusted” EPS (diluted) guidance.2011GAAP EPS (diluted) guidance$ 4.56

-

$ 4.79Known adju
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine technology :

1. Amgen’s Fourth Quarter 2010 Adjusted Earnings Per Share Increased 11 Percent to $1.17; Full Year 2010 Adjusted Earnings Per Share Increased 6 Percent to $5.21
2. Amgen’s Third Quarter 2010 Revenue Unchanged at $3.8 Billion Versus Prior Year
3. Cepheid Reports 2011 First Quarter Results
4. ViroPharma to Release 2011 First Quarter Financial Results On April 28, 2011
5. Caliper Life Sciences First Quarter Results Conference Call Notice
6. Siemens Applauds First Health System Customers to Successfully Attest to Meaningful Use
7. Cardiogenesis Corporation to Report 2011 First Quarter Results on May 4th
8. PDL BioPharma to Announce First Quarter 2011 Financial Results on April 27, 2011
9. WuXi PharmaTech Schedules First-Quarter 2011 Earnings Release
10. Masimo to Report First Quarter 2011 Financial Results After Market Close on May 3, 2011
11. MiMedx Group, Inc. Announces Release Date for First Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... Jan. 23, 2015  HyGreen, Inc., a leader in hand ... with RCA Medical, a subsidiary of Ascendis Health Limited, ... Each year, hundreds of millions of patients around ... organisms are transmitted from patient to patient via the ...
(Date:1/23/2015)... N.Y. , Jan. 23, 2015  Lixte Biotechnology Holdings, Inc. ... its Phase I trial of Lixte,s lead compound, LB‑100, is ... John S. Kovach , M.D., the founder ... planned to be completed at a single site. Accrual of ...
(Date:1/23/2015)... Jan. 23, 2015  CytoSorbents Corporation (NASDAQ CM: CTSO), ... extracorporeal cytokine adsorber to reduce deadly inflammation in ... of $385,642, net of transaction costs, in non-dilutive ... Business Tax Certificate Transfer Program sponsored by the ...
Breaking Medicine Technology:HyGreen Partners with RCA Medical in Johannesburg, South Africa 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 3
(Date:1/22/2015)... Plainsboro, NJ (PRWEB) January 22, 2015 ... advocate and keynote speaker at the upcoming 32nd ... by ACCME-accredited Physicians’ Education Resource®, LLC (PER®) , ... breast would have gone undetected if she had not ...
(Date:1/22/2015)... 22, 2015 Yesterday, Senator Holly ... and Kristin Olsen (R-Modesto) were honored by the ... advancing biotechnology, biomedical science, medical device and pharmaceutical ... received the “2014 Life Sciences Champion” award from ...
(Date:1/22/2015)... January 22, 2015 IsoComforter, Inc. has introduced ... with patented IsoTube design to treat specific body parts and ... most progressive and easy to use patented cold therapy machine ... sports related orthopedic and muscle injuries. IsoComforter has become ...
(Date:1/22/2015)... Payday lending practices in four southern states ... distress to the states that permit them, according to ... on Race and Wealth. , While they generate hundreds ... at the same time substantially depress economic activity, according ...
(Date:1/22/2015)... NY (PRWEB) January 22, 2015 As interest ... overall health care gains momentum worldwide, Rev. Eric J. ... HealthCare Chaplaincy Network (HCCN), will be the keynote speaker ... care in Israel’s public health system. , The conference, “Hope ...
Breaking Medicine News(10 mins):Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 3Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 4Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 5Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 6Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3Health News:IsoComforter Introduces Best of Class Cold Therapy Product to the Worldwide Market 2Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 3
... Reporter , TUESDAY, July 13 (HealthDay News) -- During ... members of the U.S. government panel that could decide the ... A decision on whether to ban Avandia or not ... that the drug,s maker, GlaxoSmithKline, may have buried or manipulated ...
... The decision regarding treatment following breast-conserving surgery for patients ... an area of discussion and confusion for patients and ... low, the risk of local recurrence in the breast ... and hormone treatment. While both treatments have been ...
... July 15, 2010 An immune-system protein already used to ... of cancers might also aid asthma patients, UT Southwestern Medical ... the protein interferon blocks the development of a population of ... of a class of T lymphocytes, called T helper 2 ...
... of Mississippi Medical Center and four collaborating academic medical ... of Health to identify risk factors for Alzheimer,s disease ... Mosley, UMMC professor of geriatric medicine and one of ... will pay for the ARIC Neurocognitive Study, a comprehensive ...
... Reporter , TUESDAY, July 13 (HealthDay News) -- Patients ... symptoms frequently attributed to memory problems or difficulty finding ... brain disorder may also have a reduced ability to ... from the University of Florida and other institutions showed ...
... Tolstoy portrayed Russians as a brooding, complicated people, and ... dark feelings and memories more than Westerners do. But ... though Russians tend to brood, they are less likely ... "Among Westerners, focusing on one,s negative feelings tends ...
Cached Medicine News:Health News:FDA Panel Seems Skeptical Over Key Avandia Data 2Health News:FDA Panel Seems Skeptical Over Key Avandia Data 3Health News:FDA Panel Seems Skeptical Over Key Avandia Data 4Health News:Prediction tool helps estimate local recurrence in patients with noninvasive breast cancer 2Health News:Prediction tool helps estimate local recurrence in patients with noninvasive breast cancer 3Health News:Interferon might help asthma patients breathe easier, UT Southwestern study suggests 2Health News:University of Mississippi Medical Center to lead in nationwide NIH-funded Alzheimer's study 2Health News:University of Mississippi Medical Center to lead in nationwide NIH-funded Alzheimer's study 3Health News:Emotions May Be Blunted in Alzheimer's Patients 2Health News:Emotions May Be Blunted in Alzheimer's Patients 3Health News:Brooding Russians: Less distressed than Americans 2
To maintain the conjunctival cul-de-sacs after enucleation or evisceration without hindering lid closure....
To maintain the conjunctival cul-de-sacs after enucleation or evisceration without hindering lid closure....
... plugs are coated with a ... that makes the surface slick ... and to prevent debris from ... partial occlusion. For partial stenosis. ...
With side bite Instrument recommended to catch the polypropylene thread in the nose....
Medicine Products: